NXTCL
ST
NextCell Pharma AB
Overview
NXTCL
Symbol
ST
Exchange
About stock

NextCell Pharma AB, a biopharmaceutical company, engages in the research and development of novel stem cell therapies in Sweden. The company develops ProTrans, a drug candidate comprising stem cells primarily for treating autoimmune and inflammatory diseases. It also provides Cellaviva, a stem cell bank for the family-saving of stem cells from umbilical cord blood and umbilical cord tissue.

NextCell Pharma AB was incorporated in 2014 and is based in Huddinge, Sweden.

NextCell Pharma AB dividend calculator
Report issue